Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W4206571777', 'doi': 'https://doi.org/10.2217/imt-2021-0324', 'title': 'The Dilemma of Neoadjuvant and Adjuvant Therapy in Urothelial Carcinoma: will Immunotherapy Solve the Problem?', 'display_name': 'The Dilemma of Neoadjuvant and Adjuvant Therapy in Urothelial Carcinoma: will Immunotherapy Solve the Problem?', 'publication_year': 2022, 'publication_date': '2022-01-10', 'ids': {'openalex': 'https://openalex.org/W4206571777', 'doi': 'https://doi.org/10.2217/imt-2021-0324', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/35000464'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.2217/imt-2021-0324', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S71887004', 'display_name': 'Immunotherapy', 'issn_l': '1750-743X', 'issn': ['1750-743X', '1750-7448'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310321119', 'host_organization_name': 'Future Medicine', 'host_organization_lineage': ['https://openalex.org/P4310321119'], 'host_organization_lineage_names': ['Future Medicine'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'review', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5078751201', 'display_name': 'Giacomo Nuvola', 'orcid': 'https://orcid.org/0000-0002-9498-5466'}, 'institutions': [{'id': 'https://openalex.org/I4210119117', 'display_name': 'Azienda USL di Bologna', 'ror': 'https://ror.org/02mby1820', 'country_code': 'IT', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210119117']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Giacomo Nuvola', 'raw_affiliation_strings': ['Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni - 15, Bologna, Italia'], 'affiliations': [{'raw_affiliation_string': 'Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni - 15, Bologna, Italia', 'institution_ids': ['https://openalex.org/I4210119117']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5016268842', 'display_name': 'Alessandro Rizzo', 'orcid': 'https://orcid.org/0000-0002-5257-8678'}, 'institutions': [{'id': 'https://openalex.org/I4210119117', 'display_name': 'Azienda USL di Bologna', 'ror': 'https://ror.org/02mby1820', 'country_code': 'IT', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210119117']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Alessandro Rizzo', 'raw_affiliation_strings': ['Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni - 15, Bologna, Italia'], 'affiliations': [{'raw_affiliation_string': 'Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni - 15, Bologna, Italia', 'institution_ids': ['https://openalex.org/I4210119117']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5035890926', 'display_name': 'Veronica Mollica', 'orcid': 'https://orcid.org/0000-0002-5169-3631'}, 'institutions': [{'id': 'https://openalex.org/I4210119117', 'display_name': 'Azienda USL di Bologna', 'ror': 'https://ror.org/02mby1820', 'country_code': 'IT', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210119117']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Veronica Mollica', 'raw_affiliation_strings': ['Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni - 15, Bologna, Italia'], 'affiliations': [{'raw_affiliation_string': 'Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni - 15, Bologna, Italia', 'institution_ids': ['https://openalex.org/I4210119117']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5063795761', 'display_name': 'Francesco Massari', 'orcid': 'https://orcid.org/0000-0001-6476-6871'}, 'institutions': [{'id': 'https://openalex.org/I4210119117', 'display_name': 'Azienda USL di Bologna', 'ror': 'https://ror.org/02mby1820', 'country_code': 'IT', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210119117']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Francesco Massari', 'raw_affiliation_strings': ['Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni - 15, Bologna, Italia'], 'affiliations': [{'raw_affiliation_string': 'Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni - 15, Bologna, Italia', 'institution_ids': ['https://openalex.org/I4210119117']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.339, 'has_fulltext': False, 'cited_by_count': 3, 'citation_normalized_percentile': {'value': 0.46932, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 76, 'max': 80}, 'biblio': {'volume': '14', 'issue': '4', 'first_page': '171', 'last_page': '174'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10458', 'display_name': 'Bladder and Urothelial Cancer Treatments', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10458', 'display_name': 'Bladder and Urothelial Cancer Treatments', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12695', 'display_name': 'Urinary and Genital Oncology Studies', 'score': 0.9945, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10619', 'display_name': 'Esophageal Cancer Research and Treatment', 'score': 0.9294, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.72824633}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.47256866}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.45920095}, {'id': 'https://openalex.org/C2779473830', 'wikidata': 'https://www.wikidata.org/wiki/Q1540899', 'display_name': 'MEDLINE', 'level': 2, 'score': 0.43131167}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.4133139}, {'id': 'https://openalex.org/C29456083', 'wikidata': 'https://www.wikidata.org/wiki/Q1221899', 'display_name': 'Gynecology', 'level': 1, 'score': 0.3870736}, {'id': 'https://openalex.org/C61434518', 'wikidata': 'https://www.wikidata.org/wiki/Q932510', 'display_name': 'General surgery', 'level': 1, 'score': 0.32091963}, {'id': 'https://openalex.org/C17744445', 'wikidata': 'https://www.wikidata.org/wiki/Q36442', 'display_name': 'Political science', 'level': 0, 'score': 0.0}, {'id': 'https://openalex.org/C199539241', 'wikidata': 'https://www.wikidata.org/wiki/Q7748', 'display_name': 'Law', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D017024', 'descriptor_name': 'Chemotherapy, Adjuvant', 'qualifier_ui': 'Q000379', 'qualifier_name': 'methods', 'is_major_topic': True}, {'descriptor_ui': 'D007167', 'descriptor_name': 'Immunotherapy', 'qualifier_ui': 'Q000379', 'qualifier_name': 'methods', 'is_major_topic': True}, {'descriptor_ui': 'D020360', 'descriptor_name': 'Neoadjuvant Therapy', 'qualifier_ui': 'Q000379', 'qualifier_name': 'methods', 'is_major_topic': True}, {'descriptor_ui': 'D014571', 'descriptor_name': 'Urologic Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D014571', 'descriptor_name': 'Urologic Neoplasms', 'qualifier_ui': 'Q000276', 'qualifier_name': 'immunology', 'is_major_topic': True}, {'descriptor_ui': 'D017024', 'descriptor_name': 'Chemotherapy, Adjuvant', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007167', 'descriptor_name': 'Immunotherapy', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020360', 'descriptor_name': 'Neoadjuvant Therapy', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014571', 'descriptor_name': 'Urologic Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.2217/imt-2021-0324', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S71887004', 'display_name': 'Immunotherapy', 'issn_l': '1750-743X', 'issn': ['1750-743X', '1750-7448'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310321119', 'host_organization_name': 'Future Medicine', 'host_organization_lineage': ['https://openalex.org/P4310321119'], 'host_organization_lineage_names': ['Future Medicine'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/35000464', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.78, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 22, 'referenced_works': ['https://openalex.org/W1800122197', 'https://openalex.org/W1845099892', 'https://openalex.org/W2051762085', 'https://openalex.org/W2137616140', 'https://openalex.org/W2152762320', 'https://openalex.org/W2159827893', 'https://openalex.org/W2171883057', 'https://openalex.org/W2473162054', 'https://openalex.org/W2895962428', 'https://openalex.org/W2897581535', 'https://openalex.org/W2936221437', 'https://openalex.org/W2987436342', 'https://openalex.org/W3033612535', 'https://openalex.org/W3081622691', 'https://openalex.org/W3087464965', 'https://openalex.org/W3092138236', 'https://openalex.org/W3092302767', 'https://openalex.org/W3135321607', 'https://openalex.org/W3135814171', 'https://openalex.org/W3138703636', 'https://openalex.org/W3163995648', 'https://openalex.org/W3202848091'], 'related_works': ['https://openalex.org/W4393095456', 'https://openalex.org/W4302381976', 'https://openalex.org/W4243634448', 'https://openalex.org/W2531913951', 'https://openalex.org/W2186113122', 'https://openalex.org/W2049533288', 'https://openalex.org/W1956289930', 'https://openalex.org/W175112394', 'https://openalex.org/W1608536533', 'https://openalex.org/W1523310174'], 'abstract_inverted_index': {'ImmunotherapyVol.': [0], '14,': [1, 881, 885], 'No.': [2, 882, 886], '4': [3, 887], 'CommentaryThe': [4], 'dilemma': [5], 'of': [6, 175, 224, 251, 279, 316, 337, 408, 450, 480, 487, 538, 593, 724, 760, 854, 988], 'neoadjuvant': [7, 252, 290, 411, 594, 623, 725, 768], 'and': [8, 121, 126, 150, 197, 253, 321, 325, 347, 406, 410, 517, 590, 728, 762], 'adjuvant': [9, 254, 409], 'therapy': [10, 291, 562, 624, 769], 'in': [11, 152, 200, 226, 441, 492, 596, 600, 628, 665, 695, 773, 801, 828, 851, 916, 948, 959, 985], 'urothelial': [12, 179, 201, 230, 416, 448, 495, 523, 567, 598, 632, 671, 698, 733, 803, 830], 'carcinoma:': [13], 'will': [14], 'immunotherapy': [15, 225], 'solve': [16], 'the': [17, 153, 338, 451, 601, 700, 852, 894, 953, 960, 986], 'problem?Giacomo': [18], 'Nuvola‡,': [19], 'Alessandro': [20, 46], 'Rizzo‡,': [21], 'Veronica': [22, 61], 'Mollica': [23, 62, 507], '&': [24, 76, 873, 927], 'Francesco': [25, 77], 'MassariGiacomo': [26], 'Nuvola‡': [27], '*Author': [28], 'for': [29, 182, 256, 292, 330, 371, 378, 413, 521, 563, 730, 893], 'correspondence:': [30], 'E-mail': [31], 'Address:': [32], '[email protected]://orcid.org/0000-0002-9498-5466Medical': [33], 'Oncology,': [34, 49, 64, 80], 'IRCCS': [35, 50, 65, 81], 'Azienda': [36, 51, 66, 82], 'Ospedaliero-Universitaria': [37, 52, 67, 83], 'di': [38, 53, 68, 84], 'Bologna,': [39, 44, 54, 59, 69, 74, 85, 90], 'Via': [40, 55, 70, 86], 'Albertoni': [41, 56, 71, 87], '-': [42, 57, 72, 88], '15,': [43, 58, 73, 89], 'Italia,': [45, 60], 'Rizzo‡': [47], 'https://orcid.org/0000-0002-5257-8678Medical': [48], 'https://orcid.org/0000-0002-5169-3631Medical': [63], 'Italia': [75], 'Massari': [78], 'https://orcid.org/0000-0001-6476-6871Medical': [79], 'ItaliaPublished': [91], 'Online:10': [92], 'Jan': [93], '2022AboutSectionsView': [94], 'ArticleView': [95], 'Full': [96], 'TextPDF/EPUB': [97], 'ToolsAdd': [98], 'to': [99], 'favoritesDownload': [100], 'CitationsTrack': [101], 'CitationsPermissionsReprints': [102], 'ShareShare': [103], 'onFacebookTwitterLinkedInReddit': [104], 'View': [105], 'articleKeywords:': [106], 'adjuvantbladder': [107], 'cancerimmunotherapyneoadjuvanturothelial': [108, 925], 'carcinomaReferences1.': [109], 'Antoni': [110], 'S,': [111], 'Ferlay': [112], 'J,': [113, 214, 243, 473, 653, 817], 'Soerjomataram': [114], 'I': [115], 'et': [116, 143, 172, 246, 275, 310, 365, 432, 476, 513, 558, 586, 619, 658, 689, 718, 755, 795, 822], 'al.': [117, 144, 173, 247, 276, 311, 366, 433, 477, 514, 559, 587, 620, 659, 690, 719, 756, 796, 823], 'Bladder': [118], 'cancer': [119, 180, 496, 734], 'incidence': [120], 'mortality:': [122], 'a': [123, 482, 833, 859, 945], 'global': [124], 'overview': [125], 'recent': [127], 'trends.': [128], 'Eur.': [129, 260, 350, 418], 'Urol.': [130, 261, 351, 383, 419], '71,': [131], '96–108': [132], '(2017).Crossref,': [133], 'Medline,': [134, 163, 191, 210, 265, 300, 355, 387, 423, 467, 548, 576, 609, 648, 678, 708, 785, 812, 845], 'Google': [135, 164, 192, 211, 267, 302, 357, 389, 424, 468, 505, 531, 550, 578, 611, 650, 680, 710, 747, 787, 814, 847], 'Scholar2.': [136], 'Smith': [137], 'AB,': [138], 'Deal': [139, 753], 'AM,': [140], 'Woods': [141], 'ME': [142], 'Muscle-invasive': [145], 'bladder': [146, 258, 294, 334, 374, 452, 540, 633, 777, 857], 'cancer:': [147, 699, 858], 'evaluating': [148], 'treatment': [149, 853], 'survival': [151], 'National': [154], 'Cancer': [155, 296, 542], 'Data': [156], 'Base.': [157], 'BJU': [158], 'Int.': [159], '114,': [160], '719–726': [161], '(2014).Crossref,': [162, 422], 'Scholar3.': [165], 'Galsky': [166, 269], 'MD,': [167, 270], 'Hahn': [168], 'NM,': [169], 'Rosenberg': [170], 'J': [171, 717], 'Treatment': [174], 'patients': [176, 331, 442, 629, 666, 774], 'with': [177, 332, 443, 630, 667, 775, 939, 944, 952], 'metastatic': [178, 522, 539, 566], '"unfit"': [181], 'cisplatin-based': [183], 'chemotherapy.': [184], 'J.': [185, 203, 382, 402, 498, 536, 571, 642, 779, 807], 'Clin.': [186, 499, 643, 780], 'Oncol.': [187, 204, 235, 463, 500, 644, 781, 841], '29,': [188], '2432–2438': [189], '(2011).Crossref,': [190], 'Scholar4.': [193], 'Hanna': [194], 'KS.': [195], 'Updates': [196], 'novel': [198, 518], 'treatments': [199], 'carcinoma.': [202, 417, 524, 568, 672, 804], 'Pharm.': [205], 'Pract.': [206], '25,': [207], '648–656': [208], '(2019).Crossref,': [209, 547, 608], 'Scholar5.': [212], 'Kaur': [213], 'Choi': [215], 'W,': [216, 394], 'Geynisman': [217], 'DM,': [218], 'Plimack': [219], 'ER,': [220], 'Ghatalia': [221], 'P.': [222], 'Role': [223], 'localized': [227], 'muscle': [228], 'invasive': [229], 'cancer.': [231, 259, 295, 335, 541, 778], 'Ther.': [232], 'Adv.': [233], 'Med.': [234, 572, 605, 674, 704, 808], '13,': [236], '17588359211045858': [237], '(2021).Google': [238], 'Scholar6.': [239], 'Meeks': [240], 'JJ,': [241, 392], 'Bellmunt': [242, 401, 535, 816], 'Bochner': [244], 'BH': [245], 'A': [248, 309, 403, 585, 720], 'systematic': [249, 404, 860], 'review': [250, 405], 'chemotherapy': [255, 329, 345, 370, 412, 437, 489, 729], 'muscle-invasive': [257, 293, 333, 631, 776, 802, 829, 856], '62(3),': [262], '523–533b': [263], '(2012).Crossref,': [264, 386], 'CAS,': [266, 301, 356, 388, 530, 549, 577, 610, 649, 679, 709, 786, 813, 846], 'Scholar7.': [268], 'Pal': [271], 'SK,': [272], 'Chowdhury': [273], 'S': [274], 'Comparative': [277], 'effectiveness': [278], 'gemcitabine': [280, 324, 761], 'plus': [281, 287, 662, 693, 765], 'cisplatin': [282, 288, 326, 379, 764], 'versus': [283, 435, 490, 799, 826], 'methotrexate,': [284, 318], 'vinblastine,': [285, 319], 'doxorubicin,': [286, 320], 'as': [289, 327, 622, 767], '121(15),': [297], '2586–2593': [298], '(2015).Crossref,': [299, 466], 'Scholar8.': [303], 'Pfister': [304], 'C,': [305, 715], 'Gravis': [306], 'G,': [307], 'Fléchon': [308], 'Randomized': [312], 'phase': [313, 459, 483, 639, 721, 837], 'III': [314, 484], 'trial': [315, 342, 486], 'dose-dense': [317], 'cisplatin,': [322], 'or': [323, 445, 565, 936, 942, 949, 956, 969, 974, 977, 979], 'perioperative': [328], 'analysis': [336, 592], 'GETUG/AFU': [339], 'V05': [340], 'VESPER': [341], 'secondary': [343], 'endpoints:': [344], 'toxicity': [346], 'pathological': [348], 'responses.': [349], '79(2),': [352], '214–221': [353], '(2021).Crossref,': [354, 504, 784, 811, 844], 'Scholar9.': [358], 'Mertens': [359], 'LS,': [360], 'Meijer': [361], 'RP,': [362], 'Kerst': [363, 430], 'JM': [364, 431], 'Carboplatin': [367], 'based': [368], 'induction': [369], 'nonorgan': [372], 'confined': [373], 'cancer--a': [375], 'reasonable': [376], 'alternative': [377], 'unfit': [380], 'patients?': [381], '188(4),': [384], '1108–1113': [385], 'Scholar10.': [390], 'Leow': [391], 'Martin-Doyle': [393], 'Fay': [395], 'AP,': [396], 'Choueiri': [397], 'TK,': [398], 'Chang': [399], 'SL,': [400], 'meta-analysis': [407], 'upper': [414, 493], 'tract': [415, 494], '66(3),': [420], '529–541': [421], 'Scholar11.': [425], 'Sternberg': [426], 'CN,': [427], 'Skoneczna': [428], 'I,': [429], 'Immediate': [434], 'deferred': [436], 'after': [438], 'radical': [439, 626, 771], 'cystectomy': [440, 627, 772], 'pT3-pT4': [444], 'N+': [446], 'M0': [447], 'carcinoma': [449, 599, 634, 831], '(EORTC': [453], '30994):': [454], 'an': [455, 636], 'intergroup,': [456], 'open-label,': [457, 637, 835], 'randomised': [458], '3': [460, 838], 'trial.': [461, 603, 702, 839], 'Lancet': [462, 840], '16(1),': [464], '76–86': [465], 'Scholar12.': [469], 'Birtle': [470], 'A,': [471, 510, 614, 616, 686], 'Chester': [472], 'Jones': [474], 'R': [475, 512], 'Updated': [478], 'outcomes': [479], 'POUT:': [481], 'randomized': [485], 'peri-operative': [488], 'surveillance': [491], '(UTUC).': [497], '39(Suppl.': [501], '6),': [502], '455': [503], 'Scholar13.': [506], 'V,': [508], 'Rizzo': [509], 'Montironi': [511], 'Current': [515], 'strategies': [516], 'therapeutic': [519], 'approaches': [520], 'Cancers': [525], '(Basel)': [526], '12,': [527], '1449': [528], '(2020).Crossref,': [529, 575, 677, 707], 'Scholar14.': [532], 'Nadal': [533], 'R,': [534], 'Management': [537], 'Treat.': [543], 'Rev.': [544], '76,': [545], '10–21': [546], 'Scholar15.': [551], 'Powles': [552, 580], 'T,': [553, 581], 'Park': [554], 'SH,': [555], 'Voog': [556], 'E': [557], 'Avelumab': [560], 'maintenance': [561], 'advanced': [564, 697, 732], 'N.': [569, 805], 'Engl.': [570, 806], '383(13),': [573], '1218–1230': [574], 'Scholar16.': [579], 'Kockx': [582], 'M,': [583, 819], 'Rodriguez-Vida': [584], 'Clinical': [588], 'efficacy': [589], 'biomarker': [591], 'atezolizumab': [595, 825], 'operable': [597, 669], 'ABACUS': [602], 'Nat.': [604, 673, 703], '25(11),': [606], '1706–1714': [607], 'Scholar17.': [612], 'Necchi': [613], 'Anichini': [615], 'Raggi': [617], 'D': [618], 'Pembrolizumab': [621], 'before': [625, 770], '(PURE-01):': [635], 'single-arm,': [638], 'II': [640, 758], 'study.': [641], '36(34),': [645], '3353–3360': [646], '(2018).Crossref,': [647], 'Scholar18.': [651], 'Gao': [652], 'Navai': [654], 'N,': [655, 684], 'Alhalabi': [656], 'O': [657], 'Neoadjuvant': [660], 'PD-L1': [661], 'CTLA-4': [663], 'blockade': [664], 'cisplatin-ineligible': [668], 'high-risk': [670], '26(12),': [675, 705], '1845–1851': [676], 'Scholar19.': [681], 'van': [682], 'Dijk': [683], 'Gil-Jimenez': [685], 'Silina': [687], 'K': [688], 'Preoperative': [691], 'ipilimumab': [692], 'nivolumab': [694, 798], 'locoregionally': [696], 'NABUCCO': [701], '1839–1844': [706], 'Scholar20.': [711], 'Hoimes': [712], 'CJ,': [713], 'Albany': [714], 'Hoffman-Censits': [716], 'Ib/II': [722], 'study': [723, 759], 'pembrolizumab': [726, 766], '(pembro)': [727], 'locally': [731], '(UC).': [735], 'Presented': [736], 'at:': [737], 'ESMO': [738], '2018': [739], 'Congress.': [740], 'Munich,': [741], 'Germany,': [742], '19–23': [743], 'October': [744], '2018.': [745], 'https://oncologypro.esmo.org/meeting-resources/esmo-2018-congress/A-Phase-Ib-2-study-of-neoadjuvant-pembrolizumab-pembro-and-chemotherapy-for-locally-advanced-Urothelial-Cancer-UCCrossref,': [746], 'Scholar21.': [748], 'Rose': [749], 'TL,': [750], 'Harrison': [751], 'MR,': [752], 'AM': [754], 'Phase': [757], 'split-dose': [763], '39(28),': [782], '3140–3148': [783], 'Scholar22.': [788], 'Bajorin': [789], 'DF,': [790], 'Witjes': [791], 'JA,': [792], 'Gschwend': [793, 820], 'JE': [794, 821], 'Adjuvant': [797, 824], 'placebo': [800], '384(22),': [809], '2102–2114': [810], 'Scholar23.': [815], 'Hussain': [818], 'observation': [827], '(IMvigor010):': [832], 'multicentre,': [834], 'randomised,': [836], '22(4),': [842], '525–537': [843], 'ScholarFiguresReferencesRelatedDetailsCited': [848], 'ByNeoadjuvant': [849], 'immunochemotherapy': [850], 'nonmetastatic': [855], 'reviewJulien': [861], 'Sarkis,': [862], 'Enguerrand': [863], 'Vannier,': [864], 'Georges': [865], 'Mjaess,': [866], 'Corentin': [867], 'Pochet,': [868], 'Simone': [869], 'Albisinni,': [870], 'Thierry': [871, 874], 'Quackels': [872], 'Roumeguère30': [875], 'November': [876, 904], '2022': [877, 914, 919, 921], '|': [878], 'Immunotherapy,': [879], 'Vol.': [880, 884], '17': [883], 'Follow': [888], 'us': [889], 'on': [890], 'social': [891], 'media': [892], 'latest': [895], 'updates': [896], 'Metrics': [897], 'Downloaded': [898], '144': [899], 'times': [900], 'History': [901], 'Received': [902], '29': [903], '2021': [905, 909], 'Accepted': [906], '9': [907], 'December': [908], 'Published': [910, 915], 'online': [911], '10': [912], 'January': [913], 'print': [917], 'March': [918], 'Information©': [920], 'Future': [922], 'Medicine': [923], 'LtdKeywordsadjuvantbladder': [924], 'carcinomaFinancial': [926], 'competing': [928], 'interests': [929], 'disclosureThe': [930], 'authors': [931], 'have': [932], 'no': [933], 'relevant': [934], 'affiliations': [935], 'financial': [937, 946, 950], 'involvement': [938], 'any': [940], 'organization': [941], 'entity': [943], 'interest': [947], 'conflict': [951], 'subject': [954], 'matter': [955], 'materials': [957], 'discussed': [958], 'manuscript.': [961], 'This': [962], 'includes': [963], 'employment,': [964], 'consultancies,': [965], 'honoraria,': [966], 'stock': [967], 'ownership': [968], 'options,': [970], 'expert': [971], 'testimony,': [972], 'grants,': [973], 'patents': [975], 'received': [976], 'pending,': [978], 'royalties.No': [980], 'writing': [981], 'assistance': [982], 'was': [983], 'utilized': [984], 'production': [987], 'this': [989], 'manuscript.PDF': [990], 'download': [991]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4206571777', 'counts_by_year': [{'year': 2023, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 2}], 'updated_date': '2024-12-16T09:40:44.314022', 'created_date': '2022-01-26'}